Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Does Avastin Trial Mean Roche Paid Too Much for Genentech?
Does Avastin Trial Mean Roche Paid Too Much for Genentech?
Does Avastin Trial Mean Roche Paid Too Much for Genentech?
Submitted by
admin
on April 22, 2009 - 11:27am
Source:
WSJ Online
News Tags:
Roche
cancer
Genentech
drug trials
Avastin
Headline:
Does Avastin Trial Mean Roche Paid Too Much for Genentech?
Do Not Allow Advertisers to Use My Personal information
